Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol : A meta-analysis of trials with East Asian populations.
L ZhangS ZhangY YuH JiangJunbo GePublished in: Herz (2018)
Similar to the VOYAGER meta-analysis, which reported a greater efficacy of rosuvastatin in comparison with atorvastatin and simvastatin in Caucasian patients, we found that the efficacy of rosuvastatin was superior to atorvastatin in East Asian patients with hypercholesterolemia.
Keyphrases
- systematic review
- end stage renal disease
- ejection fraction
- low density lipoprotein
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- type diabetes
- cardiovascular disease
- patient reported outcomes
- meta analyses
- coronary artery disease
- cardiovascular events
- clinical evaluation
- case control